Predictors of mortality from all causes among California patients with SCD, 1991 to 2014
Variables . | HR . | 95% CI . | P . |
---|---|---|---|
SCD complications | |||
Bleeding* | |||
Yes | 2.09 | 1.82-2.41 | <.0001 |
No | Reference | ||
Ischemic stroke* | |||
Yes | 2.41 | 1.92-3.02 | <.0001 |
No | Reference | ||
VTE/UE* | |||
Yes | 2.16 | 1.85-2.53 | <.0001 |
No | Reference | ||
Pneumonia/ACS* | |||
Yes | 1.99 | 1.72-2.29 | <.0001 |
No | Reference | ||
ONFH* | |||
Yes | 1.38 | 1.20-1.58 | <.0001 |
No | Reference | ||
Renal failure* | |||
Yes | 5.21 | 4.45-6.10 | <.0001 |
No | Reference | ||
Liver failure* | |||
Yes | 3.20 | 2.76-3.71 | <.0001 |
No | Reference | ||
Sex | |||
Female | 0.96 | 0.85-1.09 | .5498 |
Male | Reference | ||
Race/ethnicity | |||
African American | Reference | ||
Non–African American | 1.02 | 0.80-1.29 | .8876 |
Variables . | HR . | 95% CI . | P . |
---|---|---|---|
SCD complications | |||
Bleeding* | |||
Yes | 2.09 | 1.82-2.41 | <.0001 |
No | Reference | ||
Ischemic stroke* | |||
Yes | 2.41 | 1.92-3.02 | <.0001 |
No | Reference | ||
VTE/UE* | |||
Yes | 2.16 | 1.85-2.53 | <.0001 |
No | Reference | ||
Pneumonia/ACS* | |||
Yes | 1.99 | 1.72-2.29 | <.0001 |
No | Reference | ||
ONFH* | |||
Yes | 1.38 | 1.20-1.58 | <.0001 |
No | Reference | ||
Renal failure* | |||
Yes | 5.21 | 4.45-6.10 | <.0001 |
No | Reference | ||
Liver failure* | |||
Yes | 3.20 | 2.76-3.71 | <.0001 |
No | Reference | ||
Sex | |||
Female | 0.96 | 0.85-1.09 | .5498 |
Male | Reference | ||
Race/ethnicity | |||
African American | Reference | ||
Non–African American | 1.02 | 0.80-1.29 | .8876 |
Cox model is stratified by entry year and adjusted for age at entry.
Included as time-dependent covariate.